• Latest
  • Trending
  • All
  • Sport
  • Cricket
  • Odisha
Dr Reddy’s To Release COVID Anti-Viral Drug ‘Molflu’ In India Markets Next Week

Dr Reddy’s To Release COVID Anti-Viral Drug ‘Molflu’ In India Markets Next Week

5 years ago
Himachal Minister’s Remarks On Rafale, Operation Sindoor Spark Row

Himachal Minister’s Remarks On Rafale, Operation Sindoor Spark Row

2 hours ago
Cyclone Akvan

Cyclone Akvan: 15 Odisha Districts Announce Closure Of Schools

2 hours ago
TPCODL

Cyclone Akvan: TPCODL Activates Comprehensive Plan To Safeguard Power Infrastructure

3 hours ago
Odisha annual higher secondary exam 2027

CHSE Odisha Releases Annual Higher Secondary Exam-2027 Timetable

3 hours ago
K3G Nostalgia! Kareena Kapoor, Hrithik Roshan Reunite As Poo And Rohan

K3G Nostalgia! Kareena Kapoor, Hrithik Roshan Reunite As Poo And Rohan

4 hours ago
Delhi HC

Aadhaar Alone Cannot Prove Date Of Birth, Rules Delhi High Court

4 hours ago
kataka river ghats closed Nov 20, 21

Cyclone Akvan: All River Ghats & Temples In Odisha’s Kataka District To Be Closed From Nov 20

4 hours ago
Ayushmann Khurrana Calls Salman Khan The ‘OG Prem’ Ahead Of ‘Yeh Prem Mol Liya’

Ayushmann Khurrana Calls Salman Khan The ‘OG Prem’ Ahead Of ‘Yeh Prem Mol Liya’

5 hours ago
Intra circle roaming in 6 Odisha districts

Cyclone Akvan: Intra-Circle Roaming To Be Activated In 6 Odisha Districts For Uninterrupted Connectivity

5 hours ago
bank strike call on dec 3

Nationwide Bank Strike Likely On Dec 3

5 hours ago
Priyanka Chopra Shares Adorable Video Of Daughter Malti Marie Reciting Gayatri Mantra

Priyanka Chopra Shares Adorable Video Of Daughter Malti Marie Reciting Gayatri Mantra

5 hours ago
Cyclone akvan to affect flight operations

Cyclone Akvan: IndiGo Flights To & From Bhubaneswar, Kolkata, Visakhapatnam To Be Affected

6 hours ago
  • Home
  • About us
  • Career
  • Contact
  • Privacy Policy
  • Terms of Usage
Friday, November 20, 2026
No Result
View All Result
OdishaBytes
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review
No Result
View All Result
OdishaBytes
No Result
View All Result
Home COVID-19

Dr Reddy’s To Release COVID Anti-Viral Drug ‘Molflu’ In India Markets Next Week

by OB Bureau
January 4, 2022
in COVID-19, Health
Reading Time: 2 mins read
Dr Reddy’s To Release COVID Anti-Viral Drug ‘Molflu’ In India Markets Next Week
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

New Delhi: India’s drugmaker Dr Reddy’s Laboratories Ltd will launch its generic version of Merck’s antiviral COVID-19 pill, molnupiravir.

To be sold under the brand name ‘Molflu’, it has been priced at Rs 35 per capsule, a company spokesperson told mediapersons on Tuesday.

ADVERTISEMENT

The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, will come up to Rs 1,400, the NDTV quoted. In comparison, the treatment with Merck’s pill in the United States costs $700.

The recommended dose of Molnupiravir 800 mg is twice a day for five days. A patient needs to take 40 capsules containing 200 mg of medication.

“Molflu is expected to be available from early next week in pharmacies throughout (India) with particular focus on states with high caseload of COVID-19,” the company spokesperson said.

An expert panel of the Central Drugs Standard Control Organisation had last week given emergency approval for the antiviral drug Molnupiravir amid the sharp spike in coronavirus cases due to the rapidly spreading Omicron variant.

Over a dozen pharma companies including Dr Reddy’s, Torrent, Cipla, Sun Pharma,  Natco, Mylan and Hetero were in the process to roll out the oral pill.

Developed by US-based biotechnology company, Ridgeback Biotherapeutics in collaboration with US pharma giant Merck, Molnupiravir is also the first oral anti-Covid pill approved by UK’s drug regulator. The US Food and Drug Administration (USFDA) has also cleared Molnupiravir for the treatment of mild-to-moderate COVID-19 in adults, and for those who are at a high risk to severe disease.

Merck Sharp & Dohme Corp., (MSD) a subsidiary of Merck, USA, had signed licensing agreements with several generic companies, including the likes of Sun Pharma and Cipla to manufacture and supply the drug in India, and to other over 100 low and middle-income countries.

Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA and has a favorable safety and tolerability profile. India had also cleared vaccines Corbevax and Covovax.

On the other hand, Mankind Pharma’s Molulife (brand name) is also expected to cost Rs 1,400, chairman of Mankind Pharma RC Juneja informed The Economic Times.

Share196Tweet123
ADVERTISEMENT
Previous Post

Market Building In Bhubaneswar Closed After Trader-Vendor Dispute

Next Post

Odia Filmmaker Santosh Panda Comes Up With ‘Denaa’ On Children’s Education

OB Bureau

OB Bureau

Related Posts

What to Do for Hair Growth: Understanding What Actually Supports Healthy Hair

What to Do for Hair Growth: Understanding What Actually Supports Healthy Hair

by OB Brand Feature
November 1, 2026

Growing healthy hair takes time, and there is no single ingredient or routine that works for everyone. Hair growth depends...

Odisha Reports 2 New COVID-19 Cases, Total Infections Rise To 3

Odisha Reports 2 New COVID-19 Cases, Total Infections Rise To 3

by OB Bureau
July 23, 2026

Bhubaneswar: Two more persons were found positive for COVID-19 in Odisha, raising the total number of infections in the state...

covid situation

COVID-19: First Positive Case In Odisha In Brahmapur; State Govt Says No Cause For Panic

by OB Bureau
July 22, 2026

Brahmapur: Following a bunch of coronavirus cases in the past week in neighbouring Andhra Pradesh, Odisha was on high alert....

Drinking Up To 5 Cups Of Coffee A Day May Lower Risk Of Stroke, Diabetes & Heart Failure: Study

Drinking Up To 5 Cups Of Coffee A Day May Lower Risk Of Stroke, Diabetes & Heart Failure: Study

by OB Bureau
July 21, 2026

Bhubaneswar: Drinking up to five cups of plain black coffee a day is safe for most adults and may even...

Next Post
Odia Filmmaker Santosh Panda Comes Up With ‘Denaa’ On Children’s Education

Odia Filmmaker Santosh Panda Comes Up With 'Denaa' On Children's Education

OMC-Ad OMC-Ad OMC-Ad
SAI International School SAI International School SAI International School
OdishaBytes

Copyright © 2026 Frontier Media

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact
  • News Feed

Follow Us

No Result
View All Result
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review

Copyright © 2026 Frontier Media